loadpatents
name:-0.11331701278687
name:-0.03624701499939
name:-0.0013630390167236
Owens; Andrew Pate Patent Filings

Owens; Andrew Pate

Patent Applications and Registrations

Patent applications and USPTO patent grants for Owens; Andrew Pate.The latest application filed is for "pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome".

Company Profile
1.32.32
  • Owens; Andrew Pate - Huntingdon GB
  • Owens; Andrew Pate - Huntington GB
  • Owens; Andrew Pate - Saffron Walden N/A GB
  • Owens; Andrew Pate - Saffron Walden Essex GB
  • Owens; Andrew Pate - Essex GB
  • Owens; Andrew Pate - Hungtingdon GB
  • Owens; Andrew Pate - Ellington Thorpe GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 10,307,422 - Burli , et al.
2019-06-04
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20180207159 - BURLI; Roland Werner ;   et al.
2018-07-26
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,925,187 - Burli , et al. March 27, 2
2018-03-27
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,783,545 - Burli , et al. October 10, 2
2017-10-10
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20170143718 - BURLI; Roland Werner ;   et al.
2017-05-25
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,549,910 - Burli , et al. January 24, 2
2017-01-24
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20160272647 - BURLI; Roland Werner ;   et al.
2016-09-22
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome
Grant 9,371,332 - Burli , et al. June 21, 2
2016-06-21
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20160158172 - BURLI; Roland Werner ;   et al.
2016-06-09
Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome
Grant 9,260,381 - Burli , et al. February 16, 2
2016-02-16
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,227,976 - Burli , et al. January 5, 2
2016-01-05
Pyrazolopyridazines And Methods For Treating Retinal Degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20150266812 - BURLI; Roland Werner ;   et al.
2015-09-24
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20150265617 - BURLI; Roland Werner ;   et al.
2015-09-24
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
Grant 9,079,909 - Burli , et al. July 14, 2
2015-07-14
Triazine derivatives as kinase inhibitors
Grant 8,785,628 - Allen , et al. July 22, 2
2014-07-22
Quinolinone derivatives as PARP and tank inhibitors
Grant 8,778,966 - Vialard , et al. July 15, 2
2014-07-15
Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome
Grant 8,765,762 - Burli , et al. July 1, 2
2014-07-01
Pyrazolopyridazines And Methods For Treating Retinal-degerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20140121205 - Burli; Roland Werner ;   et al.
2014-05-01
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20140121197 - BURLI; Roland Werner ;   et al.
2014-05-01
Quinoline derivatives as kinase inhibitors
Grant 8,653,105 - Allen , et al. February 18, 2
2014-02-18
Quinoline derivatives as kinase inhibitors
Grant 8,637,543 - Burli , et al. January 28, 2
2014-01-28
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20130252936 - BURLI; Roland Werner ;   et al.
2013-09-26
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20130018017 - VIALARD; Jorge Eduardo ;   et al.
2013-01-17
Quinoline and Quinoxaline Derivatives as Kinase Inhibitors
App 20130018057 - Burli; Roland ;   et al.
2013-01-17
Quinoline and Quinoxaline Derivatives as Kinase Inhibitors
App 20130012517 - Allen; Daniel Rees ;   et al.
2013-01-10
Quinolinone derivatives as PARP and TANK inhibitors
Grant 8,299,256 - Vialard , et al. October 30, 2
2012-10-30
Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
App 20120095005 - Allen; Daniel Rees ;   et al.
2012-04-19
Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
App 20120077815 - Allen; Daniel Rees ;   et al.
2012-03-29
Triazine Derivatives as Kinase Inhibitors
App 20120053167 - Allen; Daniel Rees ;   et al.
2012-03-01
Quinolinone Derivatives As Parp And Tank Inhibitors
App 20100168065 - Vialard; Jorge Eduardo ;   et al.
2010-07-01
Gamma-secretase inhibitors
Grant 7,655,675 - Nadin , et al. February 2, 2
2010-02-02
Sulphones which modulate the action of gamma-secretase
Grant 7,598,386 - Castro Pineiro , et al. October 6, 2
2009-10-06
Sulphones which modulate the action of gamma secretase
Grant 7,595,344 - Castro Pineiro , et al. September 29, 2
2009-09-29
Sulphones which modulate the action of gamma secretase
App 20090131419 - Castro Pineiro; Jose Luis ;   et al.
2009-05-21
Cyclohexyl sulphones as gamma-secretase inhibitors
Grant 7,410,964 - Dinnell , et al. August 12, 2
2008-08-12
Cyclic sulfonamides for inhibition of gamma-secretase
Grant 7,342,009 - Dinnell , et al. March 11, 2
2008-03-11
Cyclic sulfonamides for inhibition of gamma-secretase
App 20080045515 - Dinnell; Kevin ;   et al.
2008-02-21
Sulphones which modulate the action of gammasecretase
App 20070213329 - Castro Pineiro; Jose Luis ;   et al.
2007-09-13
Sulphones for inhibition of gamma secretase
Grant 7,161,006 - Crawforth , et al. January 9, 2
2007-01-09
Benzodiazepine derivatives as APP modulators
Grant 7,105,509 - Castro Pineiro , et al. September 12, 2
2006-09-12
Inhibitors of Akt activity
Grant 7,098,208 - Owens , et al. August 29, 2
2006-08-29
Inhibitors of Akt activity
App 20060030564 - Owens; Andrew Pate ;   et al.
2006-02-09
Benzodiazepine derivatives as inhibitors of gamma secretase
Grant 6,995,155 - Churcher , et al. February 7, 2
2006-02-07
Novel sulphones for inhibition of gamma secretase
App 20050261276 - Crawforth, James Michael ;   et al.
2005-11-24
Inhibitors of Akt activity
Grant 6,958,334 - Owens , et al. October 25, 2
2005-10-25
Cyclohexyl sulphones as gamma-secretase inhibitors
Grant 6,890,956 - Churcher , et al. May 10, 2
2005-05-10
Gamma-secretase inhibitors
App 20050075320 - Nadin, Alan John ;   et al.
2005-04-07
Imidazo-pyridine derivatives as ligands for GABA receptors
Grant 6,872,731 - Crawforth , et al. March 29, 2
2005-03-29
Cyclic sulfonamides for inhibition of gamma-secretase
App 20040230054 - Dinnell, Kevin ;   et al.
2004-11-18
Inhibitors of akt activity
App 20040122012 - Owens, Andrew Pate ;   et al.
2004-06-24
Cyclohexyl sulphones as gamma-secretase inhibitors
App 20040121995 - Churcher, Ian ;   et al.
2004-06-24
Sulphones which modulate the action of gamma secretase
App 20040116404 - Pineiro, Jose Luis Castro ;   et al.
2004-06-17
Inhibitors of akt activity
App 20040116433 - Owens, Andrew Pate ;   et al.
2004-06-17
Benzodiazepine derivatives as app modulators
App 20040082572 - Pineiro, Jose Luis Castro ;   et al.
2004-04-29
Benzodiazepine derivatives as inhibitors of gamma secretase
App 20040024203 - Churcher, Ian ;   et al.
2004-02-05
Imidazo-pyridine derivatives as ligands for gaba receptors
App 20020188000 - Crawforth, James Michael ;   et al.
2002-12-12
Tricyclic pyridone analogues as GABA-A receptor ligands
Grant 6,133,255 - Harrison , et al. October 17, 2
2000-10-17
Morpholine derivatives and their use as therapeutic agents
Grant 5,719,149 - Finke , et al. February 17, 1
1998-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed